PMID- 37280378 OWN - NLM STAT- MEDLINE DCOM- 20230703 LR - 20240118 IS - 1365-2826 (Electronic) IS - 0953-8194 (Linking) VI - 35 IP - 6 DP - 2023 Jun TI - Defining potential targets of prenatal androgen excess: Expression analysis of androgen receptor on hypothalamic neurons in the fetal female mouse brain. PG - e13302 LID - 10.1111/jne.13302 [doi] AB - Polycystic ovary syndrome (PCOS) is a female endocrine disorder that is associated with prenatal exposure to excess androgens. In prenatally androgenized (PNA) mice that model PCOS, GABAergic neural transmission to and innervation of GnRH neurons is increased. Evidence suggests that elevated GABAergic innervation originates in the arcuate nucleus (ARC). We hypothesized that GABA-GnRH circuit abnormalities are a direct consequence of PNA, resulting from DHT binding to androgen receptor (AR) in the prenatal brain. However, whether prenatal ARC neurons express AR at the time of PNA treatment is presently unknown. We used RNAScope in situ hybridization to localize AR mRNA (Ar)-expressing cells in healthy gestational day (GD) 17.5 female mouse brains and to assess coexpression levels in specific neuronal phenotypes. Our study revealed that less than 10% of ARC GABA cells expressed Ar. In contrast, we found that ARC kisspeptin neurons, critical regulators of GnRH neurons, were highly colocalized with Ar. Approximately 75% of ARC Kiss1-expressing cells also expressed Ar at GD17.5, suggesting that ARC kisspeptin neurons are potential targets of PNA. Investigating other neuronal populations in the ARC we found that ~50% of pro-opiomelanocortin (Pomc) cells, 22% of tyrosine hydroxylase (Th) cells, 8% of agouti-related protein (Agrp) cells and 8% of somatostatin (Sst) cells express Ar. Lastly, RNAscope in coronal sections showed Ar expression in the medial preoptic area (mPOA), and the ventral part of the lateral septum (vLS). These Ar-expressing regions were highly GABAergic, and 22% of GABA cells in the mPOA and 25% of GABA cells in the vLS also expressed Ar. Our findings identify specific neuronal phenotypes in the ARC, mPOA, and vLS that are androgen sensitive in late gestation. PNA-induced functional changes in these neurons may be related to the development of impaired central mechanisms associated with PCOS-like features. CI - (c) 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. FAU - Watanabe, Yugo AU - Watanabe Y AUID- ORCID: 0000-0001-6920-5360 AD - Centre for Neuroendocrinology, Department of Anatomy, University of Otago School of Biomedical Sciences, Dunedin, New Zealand. FAU - Fisher, Lorryn AU - Fisher L AD - Centre for Neuroendocrinology, Department of Anatomy, University of Otago School of Biomedical Sciences, Dunedin, New Zealand. FAU - Campbell, Rebecca E AU - Campbell RE AUID- ORCID: 0000-0002-0309-532X AD - Centre for Neuroendocrinology, Department of Physiology, University of Otago School of Biomedical Sciences, Dunedin, New Zealand. FAU - Jasoni, Christine L AU - Jasoni CL AUID- ORCID: 0000-0002-2945-8301 AD - Centre for Neuroendocrinology, Department of Anatomy, University of Otago School of Biomedical Sciences, Dunedin, New Zealand. LA - eng GR - 18-671/Health Research Council of New Zealand/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230606 PL - United States TA - J Neuroendocrinol JT - Journal of neuroendocrinology JID - 8913461 RN - 0 (Androgens) RN - 0 (Receptors, Androgen) RN - 0 (Kisspeptins) RN - 33515-09-2 (Gonadotropin-Releasing Hormone) SB - IM MH - Humans MH - Mice MH - Female MH - Pregnancy MH - Animals MH - *Androgens/metabolism MH - Receptors, Androgen/metabolism MH - Kisspeptins/metabolism MH - Arcuate Nucleus of Hypothalamus/metabolism MH - Gonadotropin-Releasing Hormone/metabolism MH - GABAergic Neurons/physiology MH - *Polycystic Ovary Syndrome MH - Brain/metabolism MH - Virilism/metabolism OTO - NOTNLM OT - GABA OT - androgen receptor OT - kisspeptin OT - polycystic ovary syndrome OT - prenatal androgen exposure EDAT- 2023/06/07 01:07 MHDA- 2023/07/03 06:42 CRDT- 2023/06/06 23:27 PHST- 2023/04/05 00:00 [revised] PHST- 2023/01/23 00:00 [received] PHST- 2023/04/27 00:00 [accepted] PHST- 2023/07/03 06:42 [medline] PHST- 2023/06/07 01:07 [pubmed] PHST- 2023/06/06 23:27 [entrez] AID - 10.1111/jne.13302 [doi] PST - ppublish SO - J Neuroendocrinol. 2023 Jun;35(6):e13302. doi: 10.1111/jne.13302. Epub 2023 Jun 6.